Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years

NCT06216093 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infections
Respiratory Syncytial Virus (RSV)

Interventions

BIOLOGICAL: EuRSV
OTHER: Placebo Comparator

Sponsor

EuBiologics Co.,Ltd